Stock ownership · SEC 13F · Q3 2025

DRUGS MADE IN AMER ACQ II CO

A breakdown of DRUGS MADE IN AMER ACQ II CO's institutional base (CUSIP G2851K120): the holders, the concentration among them, and what changed last quarter.

$4.3M
Reported value
2
Institutions
100%
Top-5 share

The verdict

$4.3M of DRUGS MADE IN AMER ACQ II CO is reported by 2 institutions as of Q3 2025; ownership is held overwhelmingly by a small core of institutions.

2
institutions hold it
$4.3M
reported 13F value
100%
held by top 5

Based on long positions reported to the SEC as of Q3 2025; 13F omits shorts, options and non-US holdings.

How 13F ownership is computed · All tracked stocks · Concentration rankings

SEC Form 13F-HR ownership desk

CUSIP G2851K120 · Q3 2025 $4M reported

VALUE-TRACE · HOLDERS-FOCUS · CONC-DOM · PHOTO-UNK · ACTIVITY-LIGHT · BOOK-SHORT

  • VALUE-TRACE $4.3M
  • HOLDERS-FOCUS 2 filers
  • CONC-DOM 100% top-5
  • PHOTO-UNK No peer
  • ACTIVITY-LIGHT 2 new
  • BOOK-SHORT 1Q history

Read with: Ownership concentration guide - DRUGS MADE IN AMER ACQ II CO's top-five holders account for 100% of reported value — read concentration before treating any single filer as a signal.

Top Institutional Holders

# Institution Shares Value Share of reported
1 Alpine Global Management, LLC 300,000 $3.0M 69.8%
2 JPMORGAN CHASE & CO (JPM, AMJB, VYLD, JPM-PC, JPM-PD, JPM-PJ, JPM-PK, JPM-PL, JPM-PM) 129,630 $1.3M 30.2%

Investment Discretion

SEC Form 13F requires each institutional filer to report whether it exercises sole or shared discretion over a position. Among DRUGS MADE IN AMER ACQ II CO's reported holders for Q3 2025, by reported value:

Sole discretion (SOLE)
69.8%
Shared-defined discretion (DFND)
30.2%

Latest Quarter Activity · Q3 2025

New positions (2)

Alpine Global Management, LLC $3.0M
JPMORGAN CHASE & CO (JPM, AMJB, VYLD, JPM-PC, JPM-PD, JPM-PJ, JPM-PK, JPM-PL, JPM-PM) $1.3M

Frequently Asked Questions

How many institutions hold DRUGS MADE IN AMER ACQ II CO?▼
DRUGS MADE IN AMER ACQ II CO is held by 2 institutional investors per the latest SEC Form 13F filings as of Q3 2025.
What is the total institutional value of DRUGS MADE IN AMER ACQ II CO?▼
Institutions report $4.3M of DRUGS MADE IN AMER ACQ II CO as of Q3 2025.
How concentrated is ownership of DRUGS MADE IN AMER ACQ II CO?▼
The top five institutional holders account for 100% of the reported institutional value in DRUGS MADE IN AMER ACQ II CO, making ownership held overwhelmingly by a small core of institutions.
Who is the largest institutional holder of DRUGS MADE IN AMER ACQ II CO?▼
Alpine Global Management, LLC is the largest reported holder of DRUGS MADE IN AMER ACQ II CO with $3.0M across 300,000 shares as of Q3 2025.

Source: U.S. Securities and Exchange Commission (SEC) - EDGAR Form 13F-HR institutional holdings filings · Q3 2025 13F-HR discloses long US-listed equity positions of managers with $100M+ qualifying assets, filed within 45 days of period end. Short positions and most derivatives are not disclosed.

PlainFundData is rendered directly from SEC EDGAR Form 13F-HR institutional holdings filings, no number is typed in by an editor. Holder lists, concentration, and reported value on this page are aggregated live from those 13F-HR extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-16.